Jacob Sherkow's guest appearances

Jacob Sherkow

The Week in Health Law

GuidePost, A Podcast Series from The CRISPR Journal

FirstThought Focus

Leo Beletsky

Nathan Cortez

Nicole Huberfeld

Nicholas Bagley

Elizabeth Leonard

Scott Burris

Christy Ford Chapin

Thad Pope

Wendy Parmet

Sylvester Stallone

John Cogan

Ross Silverman

Alexandra Phelan

Sam Halabi

Aaron Kesselheim

OwlTail

Jacob Sherkow (Professor of Law, University of Illinois), will be discussing with our moderator, Neil Canavan, the historical significance of past intellectual property claims in the antibody space and also how to interpret existing patent law in the US and Europe as it relates to cell therapies in development. Jacob S. Sherkow is Professor of Law at the College of Law and Affiliate of the Carl R. Woese Institute for Genomic Biology at the University of Illinois, where his research focuses on the legal and ethical implications of advanced biotechnologies, especially as related to intellectual property. He is a leading expert on IP protection for genome-editing technologies, including CRISPR. Sherkow is the author of over 40 articles published in both scientific journals and traditional law reviews, including Science, Nature, the Yale Law Journal, and the Stanford Law Review.

Jacob Sherkow (Professor of Law, University of Illinois), will be discussing with our moderator, Neil Canavan, the historical significance of past intellectual property claims in the antibody space and also how to interpret existing patent law in the US and Europe as it relates to cell therapies in development. Jacob S. Sherkow is Professor of Law at the College of Law and Affiliate of the Carl R. Woese Institute for Genomic Biology at the University of Illinois, where his research focuses on the legal and ethical implications of advanced biotechnologies, especially as related to intellectual property. He is a leading expert on IP protection for genome-editing technologies, including CRISPR. Sherkow is the author of over 40 articles published in both scientific journals and traditional law reviews, including Science, Nature, the Yale Law Journal, and the Stanford Law Review.

Episode 4: Intellectual Property in the Cell Therapy Space with Jacob Sherkow

In episode #4 of GuidePost, Jacob Sherkow (New York Law School) – one of the leading academic authorities on biotech patent law – explains the twists and turns of the ongoing CRISPR patent dispute.

Ep. 4: Jacob Sherkow, CRISPR patents explained

We welcome Jacob Sherkow, a law Professor at the Innovation Center for Law and Technology, at New York Law School. There he teaches a variety of courses related to intellectual property. His research focuses on how scientific developments, especially in the biosciences, affect patent law and litigation. Prof. Sherkow is a prolific scholar, the author of over two dozen articles on these and related topics in both traditional law reviews and scientific journals. Our conversation begins with an excellent CRISPR primer before traversing some fascinating questions about gene-editing patent litigation around the world, licensing issues, and the broader array of regulatory issues encountered by such emerging technologies.

127. Sylvester Stallone’s Preference. Guest, Jacob Sherkow.